Teckro vs SmartSignals® eCOA

Teckro transforms your clinical trial protocol into a hub of communication and collaboration. It’s a digital platform that connects all study stakeholders with the knowledge they need, when they need it. Drugs from trials powered by Teckro have been granted priority review and approval by regulators in the US and Europe. Thousands of investigators and 20,000+ sites around the world rely on Teckro to execute clinical trials from biopharma sponsors, including 12 out of the Top 20 pharma companies. We support all therapeutic areas, all phases, and any trial model, whether traditional, virtual, or a hybrid approach - if Teckro isn't used on your clinical trial, ask your study manager for it.

Signant SmartSignals eCOA from Signant Health is used for collecting data from patients and caregivers in clinical Trials of new medicines. Signant SmartSignals eCOA gives patients access to specific Questionnaires, making it easy for patients to complete Wherever they go. Patients who participate in a particular clinical study get access to Signant SmartSignals eCOA for the duration of the study. The app is activated with an activation code supplied by the care personnel conducting the clinical study. Signant SmartSignals eCOA, with its easy-to-use interface and timely reminders, will help patients follow the study protocol, making their trial experience a Vital part of the data collected. Signant SmartSignals eCOA provides patient privacy and anonymity throughout their clinical trial participation. The app complies with international regulations and laws for patient privacy.